DreamCIS Inc (223250) - Total Assets
Based on the latest financial reports, DreamCIS Inc (223250) holds total assets worth ₩152.85 Billion KRW (≈ $103.58 Million USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. See 223250 net assets for net asset value and shareholders' equity analysis.
DreamCIS Inc - Total Assets Trend (2017–2024)
This chart illustrates how DreamCIS Inc's total assets have evolved over time, based on quarterly financial data.
DreamCIS Inc - Asset Composition Analysis
Current Asset Composition (December 2024)
DreamCIS Inc's total assets of ₩152.85 Billion consist of 56.1% current assets and 43.9% non-current assets.
| Asset Category | Amount (KRW) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩22.66 Billion | 19.1% |
| Accounts Receivable | ₩15.01 Billion | 12.7% |
| Inventory | ₩339.01 Million | 0.3% |
| Property, Plant & Equipment | ₩5.26 Billion | 4.4% |
| Intangible Assets | ₩2.92 Billion | 2.5% |
| Goodwill | ₩25.22 Billion | 21.3% |
Asset Composition Trend (2017–2024)
This chart illustrates how DreamCIS Inc's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. For live market cap, price, and company overview, see how much is DreamCIS Inc worth.
Key Asset Composition Facts
- Current vs. Non-Current Assets: DreamCIS Inc's current assets represent 56.1% of total assets in 2024, a decrease from 88.9% in 2017.
- Cash Position: Cash and equivalents constituted 19.1% of total assets in 2024, down from 23.3% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 23.0% of total assets, an increase from 3.0% in 2017.
- Asset Diversification: The largest asset category is goodwill at 21.3% of total assets.
DreamCIS Inc Competitors by Total Assets
Key competitors of DreamCIS Inc based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Fresenius SE & Co. KGaA
XETRA:FRE
|
Germany | €42.46 Billion |
|
MLP Saglik Hizmetleri AS
IS:MPARK
|
Turkey | TL82.20 Billion |
|
Bait Bakfar Ltd
TA:BKFR
|
Israel | ILA2.15 Billion |
|
agilon health Inc
NYSE:AGL
|
USA | $1.27 Billion |
|
Pacific Smiles Group Ltd
AU:PSQ
|
Australia | AU$163.53 Million |
|
Medical Facilities Corporation
TO:DR
|
Canada | CA$272.14 Million |
|
CareRx Corp
TO:CRRX
|
Canada | CA$253.02 Million |
|
Freedom Care Group Holdings Ltd
AU:FCG
|
Australia | AU$9.86 Million |
DreamCIS Inc - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.85 | 1.61 | 3.67 |
| Quick Ratio | 1.84 | 1.61 | 3.67 |
| Cash Ratio | 0.00 | 0.67 | 0.00 |
| Working Capital | ₩35.37 Billion | ₩22.17 Billion | ₩31.37 Billion |
DreamCIS Inc - Advanced Valuation Insights
This section examines the relationship between DreamCIS Inc's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.64 |
| Latest Market Cap to Assets Ratio | 0.00 |
| Asset Growth Rate (YoY) | 33.7% |
| Total Assets | ₩118.54 Billion |
| Market Capitalization | $78.79 Million USD |
Valuation Analysis
Below Book Valuation: The market values DreamCIS Inc's assets below their book value (0.00x), which may indicate investor concerns about asset quality or future growth.
Rapid Asset Growth: DreamCIS Inc's assets grew by 33.7% over the past year, indicating significant expansion of the company's resource base.
Annual Total Assets for DreamCIS Inc (2017–2024)
The table below shows the annual total assets of DreamCIS Inc from 2017 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | ₩118.54 Billion ≈ $80.33 Million |
+33.75% |
| 2023-12-31 | ₩88.63 Billion ≈ $60.06 Million |
+13.67% |
| 2022-12-31 | ₩77.97 Billion ≈ $52.84 Million |
+37.49% |
| 2021-12-31 | ₩56.71 Billion ≈ $38.43 Million |
+16.69% |
| 2020-12-31 | ₩48.59 Billion ≈ $32.93 Million |
+94.21% |
| 2019-12-31 | ₩25.02 Billion ≈ $16.96 Million |
+42.36% |
| 2018-12-31 | ₩17.58 Billion ≈ $11.91 Million |
+29.78% |
| 2017-12-31 | ₩13.54 Billion ≈ $9.18 Million |
-- |
About DreamCIS Inc
DreamCIS, Inc. operates as a clinical research organization in South Korea. It offers clinical development services; biostatics, data and project management, pharmacovigilance, medical writing, site start up, clinical monitoring, Dreamtrial, IWRS, and quality assurance services; medical device development services; and regulatory consulting services. The company was founded in 2000 and is headqua… Read more